Clinical Trial Update: A Study of Absorption, Metabolism, Excretion and Mass Balance After a Single Dose Administration of MK-0941 (MK-0941-016)(COMPLETED) [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating absorption, metabolism, excretion and mass balance after a single dose of MK-0941 in subjects with type 2 diabetes; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MK-0941

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED | Results posted: 2012-05-28